Research reportNon-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters
Introduction
Non-suicidal self-injury (NSSI), defined as self-injurious behavior without the intent to die, is a puzzling and poorly understood phenomenon. NSSI usually begins in adolescence, and most commonly takes the form of cutting, burning, or self-hitting (Nock and Favazza, 2007). The behavior often becomes habitual, persists into adulthood (Stanley et al., 1992, Simeon and Hollander, 2001, Nada-Raja et al., 2004) and is often treatment refractory (Perry et al., 2009). Individuals who exhibit NSSI are at increased risk for suicidal behavior (Stanley and Brodsky, 2005, Hawton and Harriss, 2006, Hawton and Harriss, 2007) with many self-injurers having a history of multiple suicide attempts (Nock et al., 2006). Self-injurers often report a compulsive quality to their behavior, typically associated with a need to relieve tension, or alleviate emotional distress or pain (Klonsky, 2007). Some reports suggest disturbances in reward circuity or pain regulation in individuals who self-injure (Kemperman, 1997, Schmahl et al., 2004), while others have associated NSSI with emotion-focused and avoidance-focused coping styles (Williams and Hasking, 2009). NSSI occurs most often in individuals diagnosed with borderline personality disorder, a disorder characterized by self-destructive behavior, impulsivity and emotional lability (APA, 1994). However, several other disorders and syndromes have been associated with this behavior, including major depression (Langbehn and Pfohl, 1993), antisocial personality disorder (Isometsa et al., 1996), dissociative identity disorder (Saxe et al., 2002), posttraumatic stress disorder (Herman, 1992), eating disorders (Paul et al., 2002), autism (Nagamitsu et al., 1997), developmental disabilities (Nagamitsu, 1993) and Lesch–Nyhan syndrome (Anderson and Ernst, 1994).
While serotonergic and dopaminergic dysfunctions have been associated with suicidal behavior (van Heeringen, 2003, Mann and Currier, 2007), several converging lines of evidence suggest that the endogenous opioid system may play a more prominent role in self-injury where there is no suicidal intent (Stanley and Siever, 2010). There is a well-established relationship between pain perception and endogenous opioids (Urban and Gebhart, 1999, Fields, 2004, Przewlocki and Przewlocka, 2001). β-endorphin and met-enkephalin, which are primarily mu- and delta-receptor agonists respectively, play a role in antinociception broadly, and are involved in a phenomenon known as stress-induced analgesia (Rubinstein et al., 1996, Yamada and Nabeshima, 1995). Dynorphin, which binds primarily to the kappa opioid receptor, has a more complex role in the pain system, and has been found to be involved not only in analgesic states (Stevens and Yaksh, 1986), but also in stress-induced hyperalgesia (Vanderah et al., 2000) and the perpetuation of neuropathic pain (Lai et al., 2006). Research has demonstrated increased pain tolerance in individuals who self-injure (Claes et al., 2006) and in patients with borderline personality disorder (Ludascher et al., 2007). Also, regional activation of mu-opioid neurotransmission has been implicated in the suppression of the affective qualities of a pain stressor and in the negative internal affective states induced in a pain challenge paradigm. Zubieta et al., 2001, Zubieta et al., 2003 found dynamic changes in mu-opioid neurotransmission in response to an experimentally-induced negative affective state. Finally, β-endorphin plays an important role in the hypothalamic-pituitary adrenal stress response system via its role as a neuromodulator of corticotrophin-releasing hormone (Williams et al., 2003). There is also some evidence that the HPA axis is dysfunctional in individuals with BPD (Carrasco et al., 2007) and in individuals with a history of NSSI (Powers and McArdle, 2003).
Few studies have directly examined endogenous opioid levels in self-injurious behavior. Coid et al. (1983) found plasma levels of met-enkephalin to be associated with the recency and severity of NSSI in habitual self-injurers with BPD, while reduced baseline (Weizman et al., 1988) but elevated post-NSSI (Sandman, 2009) plasma β-endorphin levels have been found in individuals with developmental disorders. Although these findings are suggestive of a relationship between the opioid system and NSSI, plasma neuropeptide levels may not accurately reflect central levels. Several studies have found no substantial correlation between plasma and CSF β-endorphin in humans (Nakao et al., 1980, Tsigos et al., 1993, Geracioti et al., 1993, De Riu et al., 1997). Research investigating central opioid functioning is therefore necessary if we are to understand their role in NSSI.
While the CSF concentration of endogenous opioids (β-endorphin, met-enkephalin and dynorphin) in individuals with a history of self-injury has not been examined, lower levels of endogenous opioids have been implicated in the psychiatric disorders in which a self-destructive component exists. For example, Gillberg et al. (1990) found reduced levels of CSF β-endorphin in individuals with autism. In addition, Brewerton et al. (1992) reported that CSF β-endorphin levels were lower in individuals with bulimia nervosa than in healthy controls, while Demitrack et al. (1993) found a decrease in CSF β-endorphin levels in underweight anorexic individuals. In contrast, both Brewerton et al. and Lesem et al. (1991) found no difference in CSF dynorphin concentrations between individuals with eating disorders and normal controls. Taken together, the evidence suggests that dysregulation of the endogenous opioid system, and the mu-opioid system in particular, could underlie NSSI.
There is limited research examining the relationship between monoamine function and NSSI. Although serotonergic dysfunction is hypothesized to underlie self-injurious behavior associated with Prader–Willi Syndrome (Hellings and Warnock, 1994, Kishore and Stamm, 2006) and dopamine is implicated in Lesch–Nyhan disease (Allen and Rice, 1996, Wong et al., 1996), both genetic disorders characterized by self-injury, the findings in psychiatric samples with NSSI have been mixed. In a study comparing adolescent girls with a history of NSSI and age-matched controls, Crowell et al. (2005) found lower peripheral serotonin levels in girls with a history of NSSI. However, as with the neuropeptides, peripheral measures are not strong indicators of central monoamine function (Sarrias et al., 1990). Using CSF measures, Gardner et al. (1990) found no difference between BPD individuals with NSSI and without NSSI in CSF levels of 5-HIAA and HVA.
In this study, we examine three endogenous opioids: β-endorphin; met-enkephalin; and dynorphin in depressed individuals with Cluster B personality disorders and a history of suicidal behavior. We hypothesized that CSF β-endorphin and met-enkephalin levels, but not dynorphin level, would be reduced in depressed individuals with a history of NSSI. Because dynorphin appears to be primarily involved in the induction and maintenance of dysphoric states and neuropathic pain, we did not anticipate dynorphin levels to be associated with NSSI. In addition, we also examined the CSF levels of the monoamine metabolites 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA). We hypothesized that serotonergic and dopaminergic dysfunctions would not be altered in these individuals because we propose that these dysfunctions, while related to self-injurious behavior with suicidal intent, would not be related to self-injurious behavior in which the intent is primarily to regulate emotional state and reduce tension.
Section snippets
Participants
Twenty-nine psychiatric patients at two large urban medical centers participated in the study after giving their written informed consent. The Institutional Review Boards approved the study which was part of a larger protocol investigating multiple clinical and biological aspects of NSSI and suicidal behavior. Inclusion criteria were: age 18–65 and DSM-IV (APA, 1994) Axis II diagnosis of a Cluster B personality disorder (i.e., borderline, antisocial, narcissistic, or histrionic). Exclusion
Results
The NSSI and no NSSI groups did not differ with respect to background characteristics. Age, sex, ethnicity, marital status, religious affiliation, education level, or employment rate did not differ between the groups (Table 1). All subjects were diagnosed with Cluster B personality disorder, all had BPD except one member of the NSSI group (histrionic) and two members of the no NSSI group (1 antisocial, 1 narcissistic). The rate of current major depression (about two thirds) did not differ
Discussion
This study is the first to report altered levels of CSF endogenous opioids in psychiatric patients with history of non-suicidal self-injury. We found that patients in the NSSI group had lower CSF levels of β-endorphin and met-enkephalin than a matched group of patients without NSSI but no difference in dynorphin levels between the two groups. We also found that, while serotonergic and dopaminergic dysfunctions have been reported in individuals with suicidal behavior (Mann and Currier, 2007),
Role of funding source
Funding for this study was provided by NIMH Grants # MH41847 and MH46745. The NIMH had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.
Conflict of interest
The authors of this manuscript have no financial or other relationships that are relevant to the subject matter of this research or the results described herein.
Acknowledgements
This study was supported in part by NIMH grants # MH41847 and MH46745 to Dr. Stanley.
References (93)
- et al.
Risperidone antagonism of self-mutilation in a Lesch–Nyhan patient
Prog. Neuro-Psychopharmacol. Biol. Psychiatry
(1996) - et al.
Characterization and application of a radioimmunoassay for β-endorphin using an antiserum with negligible cross-reactivity against β-lipotropin
Regul. Pept.
(1982) Long-term effects of childhood abuse on brain and neurobiology
Child Adolesc. Psychiatr. Clin. N. Am.
(2003)- et al.
Pain experience related to self-injury in eating disorder patients
Eat. behav.
(2006) - et al.
Raised plasma met-enkephalin in patients who habitually mutilate themselves
Lancet
(1983) - et al.
β-endorphin and cortisol levels in plasma and CSF following acute experimental spinal traumas
Physiol. Behav.
(1997) - et al.
Relation of dissociative phenomena to levels of cerebrospinal fluid monoamine metabolites and β-endorphin in patients with eating disorders: a pilot study
Psychiatry Res.
(1993) - et al.
Using analog baselines to assess the effects of naltrexone on self-injurious behavior
Res. Dev. Disabil.
(1999) - et al.
CSF metabolites in borderline personality disorder compared with normal controls
Biol. Psychiatry
(1990) - et al.
Cholecytokinin in human cerebrospinal fluid: concentrations, dynamics, molecular forms and relationship to fasting and feeding in health, depression and alcoholism
Brain Res.
(1993)
CSF β-endorphins in childhood neuropsychiatric disorders
Brain Dev.
Regionally selective increases in mu opioid receptor density in the brains of suicide victims
Brain Res.
Childhood trauma as a correlate of lifetime opiate use in psychiatric patients
Addict. Behav.
Prenatal stress has long-term effects on brain opiate receptors
Brain Res.
Pain assessment in self-injurious patients with borderline personality disorder using signal detection theory
Psychiatry Res.
Measurement of CSF dynorphin A 1–8 immunoreactivity in anorexia nervosa and normal-weight bulimia
Biol. Psychiatry
Elevated pain thresholds correlate with dissociation and aversive arousal in patients with borderline personality disorder
Psychiatry Res.
Non-suicidal self-injury among adolescents: diagnostic correlates and relation to suicide attempts
Psychiatry Res.
Opioids in chronic pain
Eur. J. Pharmacol.
Norepinephrine release in the amygdala in response to footshock and opioid peptidergic drugs
Brain Res.
Suicidality, impulsivity and aggression: Is there a link to 5HIAA concentration in the cerebrospinal fluid?
Psychiatry Res.
Prenatal stress alters the hypothalamic levels of methionine-enkephalin in pup rats
Neuropeptides
Autoradiographic evidence of mu-opioid receptors down-regulation after prenatal stress in offspring rat brain
Brain Res. Dev. Brain Res.
Naloxone attenuates self-abusive behavior in developmentally disabled clients
Appl. Res. Ment. Retard.
Differential nociceptive deficits in patients with borderline personality disorder and self-injurious behavior: laser-evoked potentials, spatial discrimination of noxious stimuli, and pain ratings
Pain
The endogenous euphoric reward system that reinforces physical training: a mechanism for mankind's survival
Med. Hypotheses
Central mechanisms in pain
Med. Clin. North Am.
Increased adrenal androgen functioning in children with oppositional defiant disorder: a comparison with psychiatric and normal controls
J. Am. Acad. Child Adolesc. Psych.
Low plasma immunoreactive β-endorphin levels in autism
J. Am. Acad. Child Adolesc. Psych.
Effect of opioid receptor antagonists on hypothalamic-pituitary-adrenal activity in rhesus monkeys
Psychoneuroendocrinology
Stress-induced behavioral responses and multiple opioid systems in the brain
Behav. Brain Res.
Endogenous opioids: biology and function
Annu. Rev. Neurosci.
Diagnostic and Statistical Manual of Mental Disorders
Self-injury in Lesch–Nyhan disease
J. Autism Dev. Disord.
The Schedule for Interviewing Borderlines
An inventory for measuring depression
Arch. Gen. Psychiatry
CSF β-endorphin and dynorphin in bulimia nervosa
Am. J. Psychiatry
An inventory for assessing different kinds of hostility
J. Consult. Psychol.
Treatment of obsessive–compulsive cutting behavior with naltrexone
J. Clin. Psychiatry
Hypothalamic-pituitary-adrenal axis response in borderline personality disorder without post-traumatic features
Br. J. Psychiatry
Naltrexone and self-injurious behavior: a retrospective population study
J. Clin. Psychopharmacol.
Opiate antagonists in children and adolescents
Eur. Child Adolesc. Psychiatry
Psychological, autonomic, and serotonergic correlates of parasuicide among adolescent girls
Dev. Psychopathol.
State-dependent opioid control of pain
Nat. Rev. Neurosci.
Effects of a microinjection of morphine into the amygdala on the acquisition and expression of conditioned fear and hypoalgesia in rats
Behav. Neurosci.
Risk factors for and functions of deliberate self-harm: an empirical and conceptual review
Clin. Psychol. Sci. Pract.
Cited by (159)
Characterizing chronic non-suicidal self-injury and other forms of repetitive and escalating suicide behaviour as endocannabinoid-mediated pain and reward disorders
2022, Personalized Medicine in PsychiatryThe quest for a biological phenotype of adolescent non-suicidal self-injury: a machine-learning approach
2024, Translational PsychiatryIdentifying clinical risk factors correlated with addictive features of non-suicidal self-injury among a consecutive psychiatric outpatient sample of adolescents and young adults
2024, European Archives of Psychiatry and Clinical NeuroscienceQuantifying the Importance of Non-Suicidal Self-Injury Characteristics in Predicting Different Clinical Outcomes: Using Random Forest Model
2024, Journal of Youth and Adolescence